Australia markets closed

AbCellera Biologics Inc. (ABCL)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
7.90-0.40 (-4.82%)
At close: 04:00PM EDT
8.20 +0.30 (+3.80%)
After hours: 07:41PM EDT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
489,043
375,203
233,155
11,612
8,831
Cost of revenue
70,143
45,516
27,143
-
0
Gross profit
418,900
329,687
206,012
-
8,831
Operating expenses
Research development
76,076
62,062
29,393
10,113
5,803
Selling general and administrative
56,399
48,761
15,752
4,012
2,863
Total operating expenses
128,079
107,788
41,661
13,954
7,990
Operating income or loss
290,821
221,899
164,351
-2,343
841
Interest expense
-
5,225
6,511
209.196
212
Total other income/expenses net
-455
-855
-300
186.056
-362
Income before tax
288,471
219,149
157,833
-2,211
309
Income tax expense
83,655
65,685
38,915
-
0
Income from continuing operations
204,816
153,464
118,918
-2,211
309
Net income
204,816
153,464
118,918
-2,211
309
Net income available to common shareholders
204,816
153,464
85,101
-2,211
292
Basic EPS
-
-
0.53
-0.01
0.00
Diluted EPS
-
-
0.45
-0.01
0.00
Basic average shares
-
-
159,195
172,380
215,415
Diluted average shares
-
-
263,130
172,380
237,724
EBITDA
-
241,624
169,615
-154.612
1,439